Phenolic composition, antioxidant activity, anticholinesterase potential and modulatory effects of aqueous extracts of some seaweeds on β-amyloid aggregation and disaggregation

References

• Adefegha SA, Oboh G, Olasehinde TA. 2016. Alkaloid extracts from shea butter and breadfruit as potential inhibitors of monoamine oxidase, cholinesterases, and lipid peroxidation in rats’ brain homogenates: a comparative study. Comp Clin Pathol. 25:1213–1219.
   Google Scholar
• Admassu H, Gasmalla MA, Yang R, Zhao W. 2018. Bioactive peptides derived from seaweed protein and their health benefits: antihypertensive, antioxidant, and antidiabetic properties. J Food Sci. 83:6–16.
   PubMed Web of Science ®Google Scholar
• Biradar SM, Joshi H, Chheda TK. 2014. Biochanin-A ameliorates behavioural and neurochemical derangements in cognitive-deficit mice for the betterment of Alzheimer’s disease. Human Exp Tox. 33:369–382.
   PubMed Web of Science ®Google Scholar
• Bixler HJ, Porse H. 2011. A decade of change in the seaweed hydrocolloids industry. J Appl Phycol. 23:321–335.
   Web of Science ®Google Scholar
• Burmaoglu S, Yilmaz AO, Taslimi P, Algul O, Kilic D, Gulcin I. 2018. Synthesis and biological evaluation of phloroglucinol derivatives possessing α‐glycosidase, acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase inhibitory activity. Archiv Der Pharmaziepharm Life. 351:1700314.
   Web of Science ®Google Scholar
• Carvajal FJ, Inestrosa NC. 2011. Interactions of AChE with Aβ aggregates in Alzheimer’s brain: therapeutic relevance of IDN 5706. Front Mol Neurosc. 4:1–26.
   PubMed Web of Science ®Google Scholar
• Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. 2018. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Bio. 14:450–464.
   PubMed Web of Science ®Google Scholar
• Feng Y, Wang X. 2012. Antioxidant therapies for Alzheimer's disease. Oxid Med Cell Long. 2012:472932.
   PubMed Web of Science ®Google Scholar
• Ferreira-Vieira T, Guimaraes M, Silva RL, Ribeiro F. 2016. Alzheimer's disease: targeting the cholinergic system. Curr Neuropharm. 14:101–115.
   PubMed Web of Science ®Google Scholar
• Gyamfi MA, Yonamine M, Aniya Y. 1999. Free radical scavenging action of medicinal herbs from Ghana: Thonningia sanguinea on experimentally induced liver injuries. Gen Pharm. 32:661–667.
   PubMedGoogle Scholar
• Halliwell B, Gutteridge J. 1981. Formation of thiobarbituric-acid-reactive substance from deoxyribose in the presence of iron salts: The role of superoxide and hydroxyl radicals. FEBS Lett. 128:347–352.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, et al. 2015. Neuroinflammation in Alzheimer's disease. The Lancet Neurol. 14:388–405.
   PubMed Web of Science ®Google Scholar
• Kalinski JC, Waterworth S, Siwe NX, Jiwaji M, Parker-Nance S, Krause R, McPhail K, Dorrington R. 2019. Molecular networking reveals two distinct chemotypes in pyrroloiminoquinone-producing Tsitsikamma favus sponges. Mar Drugs. 17:1–16.
   Web of Science ®Google Scholar
• Khalid S, Abbas M, Saeed F, Bader-Ul-Ain H, Suleria HAR. 2018. Therapeutic potential of seaweed bioactive compounds. Seaweed Biomaterials. Sabyasachi Maiti, IntechOpen. [accessed 2019 April 15]. https://www.intechopen.com/books/seaweed-biomaterials/therapeutic-potential-of-seaweed-bioactive-compounds.
   Google Scholar
• Lane RM, Kivipelto M, Greig NH. 2004. Acetylcholinesterase and its inhibition in Alzheimer disease. Clinical Neuropharm. 27:141–149.
   PubMed Web of Science ®Google Scholar
• Lane RM, Potkin SG, Enz A. 2006. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol. 9:101–124.
   PubMed Web of Science ®Google Scholar
• Li K, Wei S, Liu Z, Hu L, Lin J, Tan S, Mai Y, Peng W, Mai H, Hou Q, et al. 2018. The prevalence of Alzheimer's disease in China: a systematic review and meta-analysis. Iranian J Public Health. 47:1615–1626.
   PubMed Web of Science ®Google Scholar
• Lordan S, Ross RP, Stanton C. 2011. Marine bioactives as functional food ingredients: potential to reduce the incidence of chronic diseases. Marine Drugs. 9:1056–1100.
   PubMed Web of Science ®Google Scholar
• Mendiola-Precoma J, Berumen LC, Padilla K, Garcia-Alcocer G. 2016. Therapies for prevention and treatment of Alzheimer’s disease. BioMed Research Int. 2016:2589276.
   PubMed Web of Science ®Google Scholar
• Mohamed S, Hashim SN, Rahman HA. 2012. Seaweeds: a sustainable functional food for complementary and alternative therapy. Trends in Food Sci Tech. 23:83–96.
   Web of Science ®Google Scholar
• Mokhtar SH, Bakhuraysah MM, Cram DS, Petratos S. 2013. The beta-amyloid protein of Alzheimer’s disease: communication breakdown by modifying the neuronal cytoskeleton. Int J Alzheimer’s Dis. 2013:910502.
   PubMedGoogle Scholar
• Mushtaq G, Greig H, Khan NA, Kamal JM. 2014. Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus. CNS Neurol Disorders-Drug Targets. 13:1432–1439.
   PubMed Web of Science ®Google Scholar
• Oboh G, Ademosun AO, Ogunsuyi OB, Oyedola ET, Olasehinde TA, Oyeleye SI. 2018a. In vitro anticholinesterase, antimonoamine oxidase and antioxidant properties of alkaloid extracts from kola nuts (Cola acuminata and Cola nitida). J Comp Int Med. 16. [accessed 2019 Apr 15]. https://doi.org/10.1515/jcim-2016-0155.
   Google Scholar
• Oboh G, Adewuni TM, Ademiluyi AO, Olasehinde TA, Ademosun AO. 2018b. Phenolic constituents and inhibitory effects of Hibiscus sabdariffa L. (Sorrel) calyx on cholinergic, monoaminergic, and purinergic enzyme activities. J Dietary Suppl. 15:910–922.
   PubMedGoogle Scholar
• Oboh G, Agunloye OM, Akinyemi AJ, Ademiluyi AO, Adefegha SA. 2013. Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer’s disease and some pro-oxidant induced oxidative stress in rats’ brain-in vitro. Neurochemical Res. 38:413–419.
   PubMed Web of Science ®Google Scholar
• O'Brien RJ, Wong PC. 2011. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci. 34:185–204.
   PubMed Web of Science ®Google Scholar
• Olasehinde TA, Mabinya LV, Olaniran AA, Okoh AI. 2019. Chemical characterization, antioxidant properties, cholinesterase inhibitory and anti-amyloidogenic activities of sulfated polysaccharides from some seaweeds. Bioact Carb Dietary Fibre. 18:100182. [accessed 2019 May 20]. https://doi.org/10.1016/j.bcdf.2019.100182.
   Google Scholar
• Olasehinde TA, Odjadjare EC, Mabinya LV, Olaniran AO, Okoh AI. 2019. Chlorella sorokiniana and Chlorella minutissima exhibit antioxidant potentials, inhibit cholinesterases and modulate disaggregation of β-amyloid fibrils. Electronic J Biotech. 40:1–9.
   Web of Science ®Google Scholar
• Olasehinde TA, Olaniran AO, Okoh A. 2017. Therapeutic potentials of microalgae in the treatment of Alzheimer’s disease. Molecules. 22:480–418.
   Web of Science ®Google Scholar
• Olasehinde TA, Olaniran AO, Okoh AI. 2019. Aqueous–ethanol extracts of some South African seaweeds inhibit β‐amyloid aggregation, cholinesterases, and β‐secretase activities in vitro. J Food Biochem. e12870. [accessed 2019 May 15]. https://doi.org/10.1111/jfbc.12870.
   PubMed Web of Science ®Google Scholar
• Paganga G, Al-Hashim H, Khodr H, Scott BC, Aruoma OI, Hider RC, Halliwell B, Rice-Evans CA. 1996. Mechanisms of antioxidant activities of quercetin and catechin. Redox Rep: Commun Free Radical Res. 2:359–364.
   Web of Science ®Google Scholar
• Perry EK, Perry RH, Blessed G, Tomlinson BE. 1978. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol. 4:273–277.
   PubMed Web of Science ®Google Scholar
• Perry NS, Houghton PJ, Theobald A, Jenner P, Perry EK. 2000. In vitro activity of Slavandula efolia (Spanish sage) relevant to treatment of Alzheimer’s disease. J Pharm Pharm. 52:895–902.
   PubMed Web of Science ®Google Scholar
• Plaza M, Cifuentes A, Ibáñez E. 2008. In the search of new functional food ingredients from algae. Trends Food Sci Tech. 19:31–39.
   Web of Science ®Google Scholar
• Puntel RL, Nogueira CW, Rocha J. 2005. Krebs cycle intermediates modulate thiobarbituric acid reactive species (TBARS) production in rat brain in vitro. Neurochem Res. 30:225–235.
   PubMed Web of Science ®Google Scholar
• Quéguineur B, Goya L, Ramos S, Martín MA, Mateos R, Bravo L. 2012. Phloroglucinol: Antioxidant properties and effects on cellular oxidative markers in human HepG2 cell line. Food Chem Tox. 50:2886–2893.
   PubMed Web of Science ®Google Scholar
• Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. 1999. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 26:1231–1237.
   PubMed Web of Science ®Google Scholar
• Rosensweig C, Ono K, Murakami K, Lowenstein DK, Bitan G, Teplow DB. 2012. Preparation of stable amyloid β-protein oligomers of defined assembly order. In: Sigurdsson E, Calero M, Gasset M, editors. Amyloid proteins. Methods in molecular biology (Methods and Protocols). New York: Humana Press; p. 23–31.
   Google Scholar
• Shanmuganathan B, Malar DS, Sathya S, Devi KP. 2015. Antiaggregation potential of Padina gymnospora against the toxic Alzheimer’s β-amyloid peptide 25-35 and cholinesterase inhibitory property of its bioactive compounds. PloS One. 10:e0141708–14.
   PubMed Web of Science ®Google Scholar
• Shanmuganathan B, Pandima Devi K. 2016. Evaluation of the nutritional profile and antioxidant and anti-cholinesterase activities of Padina gymnospora (Phaeophyceae). European Journal of Phycology. 51(4):482–490.
   Web of Science ®Google Scholar
• Shanmuganathan B, Suryanarayanan V, Sathya S, Narenkumar M, Singh SK, Ruckmani K, Devi KP. 2018. Anti-amyloidogenic and anti-apoptotic effect of α-bisabolol against Aβ induced neurotoxicity in PC12 cells. European J Med Chem. 143:1196–1207.
   PubMed Web of Science ®Google Scholar
• Singh SK, Srivastav S, Yadav AK, Srikrishna S, Perry G. 2016. Overview of Alzheimer’s disease and some therapeutic approaches targeting Aβ by using several synthetic and herbal compounds. Oxid Med Cell Long. 2016:7361613.
   PubMed Web of Science ®Google Scholar
• Suganthy N, Devi PK. 2016. In vitro antioxidant and anti-cholinesterase activities of Rhizophora mucronata. Pharm Biol. 54:118–129.
   PubMed Web of Science ®Google Scholar
• Syad AN, Devi KP. 2015. Assessment of anti-amyloidogenic activity of marine red alga G. acerosa against Alzheimer’s β-amyloid peptide 25-35. Neurol Res. 37:14–22.
   PubMed Web of Science ®Google Scholar
• Tatsimo SJN, de Dieu Tamokou J, Havyarimana L, Csupor D, Forgo P, Hohmann J, Kuiate JR, Tane P. 2012. Antimicrobial and antioxidant activity of kaempferol rhamnoside derivatives from Bryophyllum pinnatum. BMC Res Notes. 5:1–6.
   PubMedGoogle Scholar
• Vauzour D. 2012. Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxid Med Cell Longev. 2012:914273.
   PubMed Web of Science ®Google Scholar
• Viau CM, Moura DJ, Pflüger P, Facundo VA, Saffi J. 2016. Structural aspects of antioxidant and genotoxic activities of two flavonoids obtained from ethanolic extract of Combretum leprosum. Evidence-Based Comp Alt Med. 2016:9849134.
   PubMed Web of Science ®Google Scholar
• Yang EJ, Mahmood U, Kim H, Choi M, Choi Y, Lee JP, Cho JY, Hyun JW, Kim YS, Chang MJ, et al. 2018. Phloroglucinol ameliorates cognitive impairments by reducing the amyloid β peptide burden and pro-inflammatory cytokines in the hippocampus of 5XFAD mice. Free Radic Biol Med. 126:221–234.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao B. 2013. Oxidative stress and the pathogenesis of Alzheimer's disease. Oxidative. Med Cell Longev. 2013:316523.
   Web of Science ®Google Scholar